Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
33.3%
% of MEDX's 30 holdings also in PPH
43.5%
% of PPH's 26 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 18.6% | 13.8% | 13.8% |
|
ABBVIE INC | 8.8% | 6.3% | 6.3% |
 |
NOVARTIS AG-ADR | 7.0% | 5.8% | 5.8% |
|
JOHNSON & JOHNSON | 5.3% | 7.2% | 5.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.6% | 5.1% | 5.1% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PPH
|
AMGEN INC | 6.2% |
|
ELI LILLY & CO | 4.9% |
|
ALNYLAM PHARMACEUTICALS INC | 4.5% |
 |
ALKERMES PLC | 4.1% |
|
REGENERON PHARMACEUTICALS | 2.7% |
|
CRISPR THERAPEUTICS AG | 2.6% |
|
ABBVIE INC | 2.5% |
|
BIOGEN IDEC INC | 2.4% |
|
IONIS PHARMACEUTICALS, INC. | 2.3% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% |
MEDX Underweight Relative to PPH
|
CENCORA INC | -5.8% |
|
MCKESSON CORP | -5.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -5.1% |
 |
SANOFI-AVENTIS-ADR | -5.0% |
|
ZOETIS INC | -4.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | -4.4% |
 |
TEVA PHARMACEUTICAL-SP ADR | -4.3% |
|
VIATRIS, INC. | -2.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.1% |
|
JOHNSON & JOHNSON | -1.9% |